OS rates for luminal, luminal HER‐2, HER‐2, and TN breast cancers were 94.5%, 94.3%, 85.7%, and 50.3%, respectively (P = 0.0007; Figure 1). The gene discussed is ERBB2; the disease is breast carcinoma.